These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7906263)

  • 21. A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivatives.
    Michieli M; Michelutti A; Damiani D; Pipan C; Raspadori D; Lauria F; Baccarani M
    Leuk Lymphoma; 1993 Feb; 9(3):255-64. PubMed ID: 8097129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
    Feller N; Kuiper CM; Lankelma J; Ruhdal JK; Scheper RJ; Pinedo HM; Broxterman HJ
    Br J Cancer; 1995 Sep; 72(3):543-9. PubMed ID: 7669559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumor cells.
    Sehested M; Bindslev N; Demant EJ; Skovsgaard T; Jensen PB
    Biochem Pharmacol; 1989 Sep; 38(18):3017-27. PubMed ID: 2571333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
    den Boer ML; Pieters R; Kazemier KM; Janka-Schaub GE; Henze G; Veerman AJ
    Leukemia; 1998 Jun; 12(6):912-20. PubMed ID: 9639420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics and metabolism of a new fluoropyrimidine, 5'-deoxy-5-fluorouridine, in humans.
    Sommadossi JP; Aubert C; Cano JP; Gouveia J; Ribaud P; Mathé G
    Cancer Res; 1983 Feb; 43(2):930-3. PubMed ID: 6216947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of administration route in the therapeutic efficacy of doxifluridine.
    Trave F; Canobbio L; Au JL; Rustum YM
    J Natl Cancer Inst; 1987 Mar; 78(3):527-32. PubMed ID: 2950266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.
    Yang JY; Luo HY; Lin QY; Liu ZM; Yan LN; Lin P; Zhang J; Lei S
    World J Gastroenterol; 2002 Aug; 8(4):644-9. PubMed ID: 12174371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon alpha and 5'-deoxy-5-fluorouridine in colon cancer: effects as single agents and in combination on growth of xenograft tumours.
    Laurent PL; Tevaearai HT; Eliason JF; Givel JC; Odartchenko N
    Eur J Cancer; 1994; 30A(12):1859-65. PubMed ID: 7880618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
    Nielsen D; Skovsgaard T
    Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.
    Versantvoort CH; Schuurhuis GJ; Pinedo HM; Eekman CA; Kuiper CM; Lankelma J; Broxterman HJ
    Br J Cancer; 1993 Nov; 68(5):939-46. PubMed ID: 8105867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
    Nagasawa K; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
    Biol Pharm Bull; 1996 Jul; 19(7):971-6. PubMed ID: 8839972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-transporter proteins in clinical multidrug resistance.
    Scheper RJ; Broxterman HJ; Scheffer GL; Meijer CJ; Pinedo HM
    Clin Chim Acta; 1992 Mar; 206(1-2):25-32. PubMed ID: 1349270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5'-deoxy-5-fluorouridine.
    Eda H; Fujimoto K; Watanabe S; Ishikawa T; Ohiwa T; Tatsuno K; Tanaka Y; Ishitsuka H
    Jpn J Cancer Res; 1993 Mar; 84(3):341-7. PubMed ID: 8486533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposome-encapsulated daunorubicin for PGP-related multidrug resistance.
    Michieli M; Damiani D; Ermacora A; Masolini P; Michelutti A; Michelutti T; Russo D; Pea F; Baccarani M
    Br J Haematol; 1999 Jul; 106(1):92-9. PubMed ID: 10444168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmentation of antitumor activity of 5'-deoxy-5-fluorouridine by thymosin fraction 5 in mouse bladder cancer cells in vitro and in vivo.
    Ikemoto S; Sugimura K; Wada S; Yasumoto R; Yamamoto K; Kishimoto T
    Cancer Lett; 1999 Oct; 145(1-2):121-6. PubMed ID: 10530779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.
    Sehested M; Skovsgaard T; Jensen PB; Demant EJ; Friche E; Bindslev N
    Br J Cancer; 1990 Jul; 62(1):37-41. PubMed ID: 1975202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
    Mankhetkorn S; Garnier-Suillerot A
    Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
    Safa AR; Agresti M; Bryk D; Tamai I
    Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of interferon-alpha 2a with 5'-deoxy-5-fluorouridine in colorectal cancer cells in vitro.
    Tevaearai HT; Laurent PL; Suardet L; Eliason JF; Givel JC; Odartchenko N
    Eur J Cancer; 1992; 28(2-3):368-72. PubMed ID: 1534247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.